Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Activity) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $) In Thousands, except Per Share data, unless otherwise specified	9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Rights, Outstanding at beginning of period	446
Number of Rights, Exercised	(124)
Number of Rights, Granted	108	185
Number of Rights, Forfeited	(5)
Number of Rights, Outstanding at end of period	425
Number of Rights, Exercisable and vested at end of period	162
Number of Rights, Vested and expected to vest at end of period	416
Weighted Average Exercise Price, Outstanding at beginning of period	$ 60.55
Weighted Average Exercise Price, Exercised	$ 52.82
Weighted Average Exercise Price, Granted	$ 72.67
Weighted Average Exercise Price, Forfeited	$ 63.50
Weighted Average Exercise Price, Outstanding at end of period	$ 65.88
Weighted Average Exercise Price, Exercisable and vested at end of period	$ 61.21
Weighted Average Exercise Price, Vested and expected to vest at end of period	$ 65.86
Weighted Average Remaining Contractual Life in Years, Outstanding at end of period	3 years 7 months 24 days
Weighted Average Remaining Contractual Life in Years, Exercisable and vested at end of period	2 years 9 months 4 days
Weighted Average Remaining Contractual Life in Years, Vested and expected to vest at end of period	3 years 7 months 24 days
Aggregate Intrinsic Value, Outstanding at end of period	$ 4,723
Aggregate Intrinsic Value, Exercisable and vested at end of period	2,552
Aggregate Intrinsic Value, Vested and expected to vest at end of period	$ 4,629